Lack of association between VEGF -2578C/A polymorphism and risk of colorectal cancer in an Iranian population
- PMID: 33585003
- PMCID: PMC7881395
Lack of association between VEGF -2578C/A polymorphism and risk of colorectal cancer in an Iranian population
Abstract
Aim: Here, we evaluated the VEGF gene -2578C/A polymorphism as a potential susceptibility factor in colorectal cancer (CRC) occurrence amongst Iranian CRC patients.
Background: Vascular endothelial growth factor (VEGF) is a key regulatory factor in angiogenesis which plays essential roles in the development of malignancy in colorectal cancer (CRC), as the third most prevalent cancer worldwide.
Methods: VEGF -2578C/A polymorphism was evaluated in 200 CRC patients and 200 healthy control subjects via restriction fragment length polymorphism analysis.
Results: The frequencies of CC, AC and AA genotypes among CRC patients were 22.5%, 51% and 26.5%, respectively, with their respective genotype frequencies at 16%, 54% and 30% in control cohorts (P=0.247). The A allele frequency among the case group was 52% and for control group, it was 57%. C allele frequency in case and control groups was 48% and 43%, respectively (p=0.156). No significant association was observed (p=0.990) between this polymorphism and CRC stage.
Conclusion: Our findings provide limited support for the hypothesis that the -2578C/A VEGF are associated with increased risk of colorectal cancer in Iranian colorectal cancer patients and suggest instead that meta data studies, which have previously relied upon populations definitions such as 'Asian', should more specifically take into account country of origin when associating prognostic value to a given genotype.
Keywords: Angiogenesis; Colorectal cancer; Single nucleotide polymorphism; VEGF; Vascular endothelial growth factor.
©2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases.
Similar articles
-
Vascular endothelial growth factor -2578C/A polymorphism and colorectal cancer risk: A meta-analysis.J Res Med Sci. 2015 Aug;20(8):811-7. doi: 10.4103/1735-1995.168406. J Res Med Sci. 2015. PMID: 26664430 Free PMC article. Review.
-
Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update.Biomed Rep. 2014 Nov;2(6):823-830. doi: 10.3892/br.2014.317. Epub 2014 Jul 15. Biomed Rep. 2014. PMID: 25279153 Free PMC article.
-
Relationship between vascular endothelial growth factor -2578C > a gene polymorphism and lung cancer risk: a meta-analysis.BMC Med Genet. 2020 Jan 29;21(1):17. doi: 10.1186/s12881-019-0938-0. BMC Med Genet. 2020. PMID: 31996156 Free PMC article.
-
VEGF-2578C/A, -460T/C Polymorphisms and Gastrointestinal Tract Cancer Risk: An Updated Meta-Analysis.Genet Test Mol Biomarkers. 2024 May;28(5):176-188. doi: 10.1089/gtmb.2023.0628. Epub 2024 Apr 10. Genet Test Mol Biomarkers. 2024. PMID: 38597641
-
Association between Polymorphisms in Vascular Endothelial Growth Factor Gene and Response to Chemotherapies in Colorectal Cancer: A Meta-Analysis.PLoS One. 2015 May 8;10(5):e0126619. doi: 10.1371/journal.pone.0126619. eCollection 2015. PLoS One. 2015. PMID: 25955730 Free PMC article. Review.
Cited by
-
Impact of VEGFA promoter polymorphisms on esophageal cancer risk in North-West Indians: a case-control study.Genes Genomics. 2022 Aug;44(8):923-936. doi: 10.1007/s13258-022-01269-2. Epub 2022 Jun 29. Genes Genomics. 2022. PMID: 35767183
References
-
- Qasim Alhilfia HS, Mohsin Almohammadawi KO, Abduljalil Alsaad RK, Ameen NA, Abbood Aliedani BK, Imran Aldubaisi HJ, et al. Colorectal cancer epidemiology and clinical study in Misan. J Coloproctol. 2019;39:159–62.
-
- Haddad FG, Eid R, Kourie HR, Barouky E, Ghosn M. Prognostic and predictive biomarkers in nonmetastatic colorectal cancers. Future Oncol. 2018;14:21. - PubMed
-
- Mo Bae J, Rhee YY, Kim KJ, Wen X, Seok Song Y, Cho NY, et al. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype–high colorectal cancers? Human Pathol. 2016;47:85–94. - PubMed
-
- Chayeb V, Mahjoub S, Zitouni H, Jrah-Harzallah H, Zouari K. Contribution of microRNA-149, microRNA-146a, and microRNA-196a2 SNPs in colorectal cancer risk and clinicopathological features in Tunisia. Gene. 2018;666:100–7. - PubMed
LinkOut - more resources
Full Text Sources